Type 2 Diabetes Mellitus- Pipeline Insight, 2022
AstraZeneca's diabetes drug Farxiga fails in COVID-19 study | Reuters
Here's Why Pfizer (NYSE:PFE) Gained Yesterday - TipRanks.com
How Pfizer's Allergan Purchase Will Boost Its Drug Pipeline - Knowledge at Wharton
Type 2 Diabetes Market to Grow Rapidly, Predicts DelveInsight | Key Companies Active in the Domain - Eli Lilly and Company, Regor, AstraZeneca, Eccogene, Pfizer, Novo Nordisk, Novartis, Amgen, MediciNova
Is Pfizer's Research Pipeline Truly Undervalued? (NYSE:PFE) | Seeking Alpha
The 20 Hottest Pipeline Drugs to Watch in 2019 | BioSpace
Pfizer CEO eyes $90B Lilly, Novo battle in diabetes, obesity
Merck, Pfizer Double Size of Diabetes Drug Study to Catch Rivals - Bloomberg
Aktie: Eli Lilly ist der neue Star der Pharmabranche
There are many products in the production pipeline for Type 1 Diabetes, says GlobalData - Pharmaceutical Technology
Pfizer's diabetes drug results in similar weight loss levels as Novo's Ozempic | Reuters
Pfizer Inc | Access to Medicine Foundation
2023 Pipeline Report: Testing the Limits
AstraZeneca boasts of strong drug pipeline as Pfizer deadline looms | AstraZeneca | The Guardian
Pfizer: Can Pfizer Grow To Targets With LOE Headwinds Ahead? | investing.com
Pfizer Stock: Is PFE Stock A Buy As It Shores Up Its Pipeline Ahead Of Expected Declines? | Investor's Business Daily
Pfizer drops diabetes and cancer drugs from clinical pipeline | Fierce Biotech
Fresh from the biotech pipeline: fewer approvals, but biologics gain share | Nature Biotechnology
Pfizer Talks Up Its Pipeline (NYSE:PFE) | Seeking Alpha
25 promising pipeline drugs - Drug Discovery and Development
New Drug Development Pipeline: Pfizer's Medicine, Vaccine Discovery
Obesity | Pfizer
Pfizer's Pipeline Makes Progress as Sales Grow - WSJ
Pfizer pins hopes on record pipeline to recover from post-Covid hangover | Financial Times
Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
